TRIPHROCAPS- folic acid, ascorbic acid, niacinamide, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin,

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

folic acid (UNII: 935E97BOY8) (folic acid - UNII:935E97BOY8), ascorbic acid (UNII: PQ6CK8PD0R) (ascorbic acid - UNII:PQ6CK8PD0R), niacinamide (UNII: 25X51I8RD4) (niacinamide - UNII:25X51I8RD4), thiamine mononitrate (UNII: 8K0I04919X) (THIAMINE ION - UNII:4ABT0J945J), riboflavin (UNII: TLM2976OFR) (riboflavin - UNII:TLM2976OFR), pyridoxine Hydrochloride (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z), cyanocobalamin (UNII: P6YC3EG204) (cyanocobalamin - UNII:P6YC3EG204), calcium pantothenate (UNII: 5

Available from:

Trigen Laboratories, LLC

INN (International Name):

folic acid

Composition:

folic acid 1 mg

Administration route:

ORAL

Therapeutic indications:

TriphroCaps are contraindicated in patients with a known hypersensitivity to any of the ingredients including soy.

Product summary:

TriphroCaps are supplied in bottles of 100 softgel capsules. Product Code: 13811-525-01

Authorization status:

Dietary Supplement

Summary of Product characteristics

TRIPHROCAPS- FOLIC ACID, ASCORBIC ACID, NIACINAMIDE, THIAMINE
MONONITRATE,
RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, CALCIUM
PANTOTHENATE,
AND BIOTIN CAPSULE
TRIGEN LABORATORIES, LLC
----------
TRIPHROCAPS
SOFTGELS
SUPPLEMENT FACTS
OTHER INGREDIENTS: SOYBEAN OIL, BOVINE GELATIN, GLYCERIN, WATER,
YELLOW
BEESWAX, LECITHIN, TITANIUM DIOXIDE, FD&C RED #40, ETHYL VANILLIN,
FD&C
YELLOW #5, FD&C YELLOW #6, AND IRON OXIDE RED
THIS PRODUCT CONTAINS SOY. TriphroCaps are an orally administered prescription vitamin used for
the dietary
management of patients with nutritional deficiencies or are in need of
nutritional
supplementation.
CONTRAINDICATIONS
TriphroCaps are contraindicated in patients with a known
hypersensitivity to any of the
ingredients including soy.
PRECAUTIONS
Folic acid alone is an improper therapy in the treatment of pernicious
anemia and other
megaloblastic anemias where Vitamin B
is deficient. Folic acid in doses above 0.1 mg
daily may obscure pernicious anemia in that hematologic remission can
occur while
neurological manifestations remain progressive.
The patient’s medical conditions and consumption of other drugs,
herbs, and/or
supplements should be considered.
PEDIATRIC USE: Safety and effectiveness in pediatric patients have not
been established.
GERIATRIC USE: Safety and effectiveness in elderly patients have not
been established.
Biotin levels higher than the recommended daily allowance may cause
interference with
some laboratory tests, including cardiovascular diagnostic tests (e.g.
troponin) and
hormone tests, and may lead to incorrect test results. Tell your
healthcare provider
about all prescription and over-the-counter medicines, vitamins, and
dietary
supplements that you take, including biotin.
This product contains FD&C Yellow No. 5 (tartrazine) which may cause
allergic-type
reactions (including bronchial asthma) in certain susceptible
patients. Although the
overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the
general population is
low, it is frequently seen i